Podcast As USPSTF falters, the idea that “screening is always good” is gaining traction October 21, 2026
PodcastThe Directors VCU’s Baskin and UNC’s Ferris weigh oncology’s looming dilemma—MCDsCenter directors are strategizing for likely FDA approval of GRAIL’s Galleri October 16, 2026Vol.52 No.38By Sara Willa Ernst and Paul Goldberg
Podcast As FDA sidesteps the question of Galleri’s clinical benefit, NCI’s Letai has “some concerns” October 14, 2026
Podcast Anthony Letai reflects on Year One as NCI Director: “The NCI is in business” October 07, 2026
PodcastThe Directors The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want itLucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish September 25, 2026Vol.52 No.35By Claire Marie Porter and Paul Goldberg
Podcast 36 months to live, 29 months to wait. Why is Congress withholding lifesaving benefits from breast cancer patients? September 23, 2026
Podcast As daraxonrasib hits the clinic, Frank McCormick says RAS is bigger than pancreatic cancer September 09, 2026
